You have 9 free searches left this month | to do more

ifosfamide

Ifosfamide is a drug used to treat Sarcoma, Lymphoma, Leukemia, and other conditions. Ifosfamide is being actively studied in 73 studies and prior, has been studied in 144.

Top SponsorsTop SitesTop Investigators
Children's Oncology GroupMemorial Sloan-Kettering Cancer CenterMartin Schrappe
Memorial Sloan Kettering Cancer CenterRoswell Park Cancer InstituteAjay Gopal
M.D. Anderson Cancer CenterChildren's National Medical CenterChristopher Ryan
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
O
Recruiting
  • Soft Tissue Sarcoma
  • Bergen, Norway
  • +1 more
2021-09-10
Sep 10, 2021
J
Terminated
  • Sarcoma
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
2020-07-29
Jul 29, 2020
I
Recruiting
  • Non-metastatic Soft-tissue Sarcoma
  • Resectable
  • Bordeaux, France
  • +9 more
2022-02-01
Feb 1, 2022
S
Recruiting
  • Penile Cancer
  • Albumin-Bound Paclitaxel
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
2020-08-18
Aug 18, 2020
E
Terminated
  • Sarcoma, Soft Tissue
  • Brussels, Belgium
  • +12 more
2021-09-10
Sep 10, 2021
U
Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-29
Dec 29, 2021
M
Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-08-11
Aug 11, 2021
I
Completed
  • Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Center
2022-01-27
Jan 27, 2022
P
Withdrawn
  • Effect of Drugs
  • +2 more
  • Beijing, Beijing, China
    Lu Xie
2020-05-15
May 15, 2020
U
Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
2022-02-02
Feb 2, 2022
T
Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • Brugge, Belgium
  • +21 more
2021-05-05
May 5, 2021
M
Active, not recruiting
  • Sarcoma
  • pegfilgrastim
  • +5 more
  • Baltimore, Maryland
  • +1 more
2022-03-25
Mar 25, 2022
S
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Seattle, Washington
    Swedish Cancer Institute
2021-03-01
Mar 1, 2021
I
Completed
  • Germ Cell Tumors
  • Angers, France
  • +11 more
2021-01-11
Jan 11, 2021
R
Active, not recruiting
  • CD20 Positive
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2021-10-11
Oct 11, 2021
C
Active, not recruiting
  • Pleuropulmonary Blastoma
  • Minneapolis, Minnesota
    Anne K Harris
2021-05-26
May 26, 2021
F
Recruiting
  • Sarcoma, Soft Tissue
  • Shanghai, Shanghai, China
    Fudan University, Cancer Hospital
2020-07-13
Jul 13, 2020
I
Not yet recruiting
  • Retroperitoneal Sarcoma
  • Resectable Sarcoma
  • Bordeaux, France
  • +3 more
2022-03-04
Mar 4, 2022
N
Recruiting
  • Non-Hodgkin Lymphoma
  • +5 more
  • Valhalla, New York
    New York Medical College
2021-09-01
Sep 1, 2021
U
Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • Miami, Florida
    University of Miami
2021-10-25
Oct 25, 2021
N
Recruiting
  • NK-Cell Lymphoma
  • +2 more
  • San Francisco, California
  • +1 more
2021-09-01
Sep 1, 2021
M
Active, not recruiting
  • Testicular Cancer
  • Houston, Texas
  • +1 more
2021-01-06
Jan 6, 2021